Stay updated on ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Sign up to get notified when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.

Latest updates to the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study record history now shows the latest revision as v3.6.4, replacing the previous v3.6.3. This indicates a minor update to the page's revision metadata in the history view.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe record history now includes a new revision labeled v3.6.3, replacing the previous v3.6.2.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry (v3.6.2) was added to the study's record history and the older revision (v3.6.0) was removed from the list. This reflects an update to the page's version history rather than changes to the study content.SummaryDifference0.1%

- Check56 days agoChange DetectedNew June 2026 entries were added to the Record History, including items such as 'Check who can join', 'Find Contact Information', and 'Study Status', along with a page revision note 'Revision: v3.6.0'.SummaryDifference2%

- Check63 days agoChange DetectedA new revision entry (v3.5.5) has been added to the record history, and the previous revision entry (v3.5.4) has been removed from the list.SummaryDifference0.1%

- Check85 days agoChange DetectedA new revision entry, v3.5.4, was added to the study's record history, indicating an updated version of the record and replacing the previous v3.5.3 in the history timeline.SummaryDifference0.1%

Stay in the know with updates to ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.